Protagonist Therapeutics, Inc (PTGX)

SEC filing

Protagonist Therapeutics, Inc

PTGX · CIK 1377121

4 · Oct 2, 2026 · Chief Financial Officer Ali Asif sold 58.63K shares at $141.78/share ($8.3M); exercised options for 117.26K shares

Chief Financial Officer Ali Asif sold 58.63K shares at $141.78/share ($8.3M); exercised options for 117.26K shares

OWNERSHIP DOCUMENT

xslF345X06/tm2626857-1_4seq1.xmlSEC.gov

Graphics and non-inline formats (not embedded below).